Assessment of liver stiffness in subjects affected by familial combined hyperlipidaemia with hepatic steatosis

European Journal of Clinical Investigation

Volumn 40, Issue 8, 2010, Pages 722-728

  Riggio, Stefania ^a   Mamone, Federica ^a   Mandraffino, Giuseppe ^a   Maimone, Sergio ^a   Alibrandi, Angela ^a   Manti, Lauretta ^a   Saitta, Carlo ^a   Tripodi, Pier Francesco ^a   Sardo, Maria Adriana ^a   Squadrito, Giovanni ^a   Saitta, Antonino ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Dyslipidaemia; fibroscan; insulin resistance; liver stiffness; metabolic syndrome; NAFLD

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE; CAROTID ARTERY; CONTROLLED STUDY; DISEASE COURSE; ECHOGRAPHY; ELASTOGRAPHY; FAMILIAL HYPERLIPEMIA; FEMALE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LIVER DISEASE; LIVER FIBROSIS; LIVER STIFFNESS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; RISK FACTOR; TRANSIENT ELASTOGRAPHY; WAIST CIRCUMFERENCE;

ADULT; CAROTID ARTERIES; DISEASE PROGRESSION; ELASTICITY IMAGING TECHNIQUES; FATTY LIVER; FEMALE; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 77954480447     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02323.x     Document Type: Article

References (32)

1. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 1973 52 : 1544 1568.
2. Venkatesan S, Cullen P, Pacy P, Halliday D, Scott J. Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia. Arterioscler Thromb 1993 13 : 1110 1118.
3. Kissebah AH, Alfarsi S, Adams PW. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia. Metabolism 1981 30 : 856 868.
4. Cabezas MC, de Bruin TW, Jansen H, Kock LA, Kortlandt W, Erkelens DW. Impaired chylomicron remnant clearance in familial combined hyperlipidemia. Arterioscler Thromb 1993 13 : 804 814.
5. de Bruin TW, Georgieva AM, Brouwers MC, Heitink MV, van der Kallen CJ, van Greevenbroek MM. Radiological evidence of nonalcoholic fatty liver disease in familial combined hyperlipidemia. Am J Med 2004 116 : 847 849.
6. Adiels M, Taskinen MR, Packard C, Caslake MJ, Soro-Paavonen A, Westerbacka J et al. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia 2006 49 : 755 756.
7. Brouwers MC, Bilderbeek-Beckers MA, Georgieva AM, van der Kallen CJ, van Greevenbroek MM, de Bruin TW. Fatty liver is an integral feature of familial combined hyperlipidaemia: relationship with fat distribution and plasma lipids. Clin Sci (Lond) 2007 112 : 123 130.
8. McCullough AJ. Pathophysiology of non-alcoholic steatohepatitis. J Clin Gastroenterol 2006 40 (Suppl. 1 S17 29.
9. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003 38 : 1449 1457. (Pubitemid 37466971)
10. Guido M, Rugge M. Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis 2004 24 : 89 97.
11. Sebastiani G. Non-invasive assessment of liver fibrosis in chronic liver diseases: implementation in clinical practice and decisional algorithms. World J Gastroenterol 2009 14 : 15.
12. Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003 29 : 1705 1713.
13. Sniderman AD, Castro Cabezas M, Ribalta J, Carmena R, de Bruin TW, de Graaf J et al. A proposal to redefine familial combined hyperlipidaemia - third workshop on FCHL held in Barcelona from 3 to 5 May 2001, during the scientific sessions of the European Society for Clinical Investigation. Eur J Clin Invest 2002 32 : 71 3.
14. Coleman A, Freeman P, Steel S, Shennan A. Validation of the Omron 705IT (HEM-759-E) oscillometric blood pressure monitoring device according to the British Hypertension Society protocol. Blood Press Monit 2006 11 : 27 32.
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 : 412 419.
16. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001 285 : 2486 2497.
17. Palmentieri B, de Sio I, La Mura V, Masarone M, Vecchione R, Bruno S et al. The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis 2006 38 : 485 489.
18. Pesarin F. Multivariate Permutation Tests with applications in Biostatistics.
19. Cavea M, Deaciuca I, Mendeza C, Songa Z, Joshi-Barvea S, Barvea S et al. Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition. J Nutr Biochem 2007 18 : 184 195.
20. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001 50 : 1844 1850.
21. Duvnjak M, Lerotić I, Baršić N, Tomaš ić V, Jukić LV, Velagić V. Pathogenesis and management issue for non-alcoholic fatty liver disease. World J Gastroenterol 2007 13 : 4539 4550.
22. Saito H, Tada S, Nakamoto N, Kitamura K, Horikawa H, Kurita S et al. Efficacy of non-invasive elastometry on staging of hepatic fibrosis. Hepatol Res 2004 29 : 97 103.
23. Castéra L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005 128 : 343 350.
24. Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005 41 : 48 54.
25. Marcellin P, Ziol M, Bedossa P, Douvin C, Poupon R, de Lédinghen V et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 2009 29 : 242 247.
26. Yoneda M, Mawatari H, Fujita K, Endo H, Iida H, Nozaki Y et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig Liver Dis 2008 40 : 371 378.
27. Roulot D, Czernichow S, Le Clésiau H, Costes JL, Vergnaud AC, Beaugrand M. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol 2008 48 : 606 613.
28. Suzuki A, Angulo P, Lymp J, Li D, Satomura S, Lindor K. Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease. Liver Int 2005 25 : 779 786.
29. Guha NI, Parkes J, Roderick PR, Harris S, Rosenberg WM. Non invasive markers associated with liver fibrosis in non alcoholic fatty liver disease. Gut 2006 55 : 1650 1660.
30. Petta S, Cammà C, Di Marco V, Calvaruso V, Enea M, Bronte F et al. Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis. Aliment Pharmacol Ther 2009 15 30 : 603 613. Epub 25 June 2009.
31. Svegliati-Baroni G, Ridolfi F, Di Sario A, Cassini A, Marucci L, Gaggiotti G et al. Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways. Hepatology 1999 29 : 1743 1751.
32. Paradis V, Perlemuter G, Bonvoust F, Dargere D, Parfait B, Vidaud M et al. High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis. Hepatology. 2001 34 (4 Pt 1 738 744.